People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics Inc | — | Biotechnology | Series B | $24.5M | $694.6M | 2013 |
Nicholas Peace at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicholas Peace on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Armen Shanafelt | 1 | 3 |
| Asish K Xavier | 1 | 3 |
| Paul F. Truex | 1 | 2 |
| Harold E. Selick, Ph.D. | 1 | 2 |
| Harold Selick | 1 | 2 |
| Dinesh Patel, PhD | 1 | 1 |
| Asish K. Xavier, Ph.D. | 1 | 1 |
| Michael K. Panaccio, Ph.D. | 1 | 1 |
| Armen V. Shanafelt, Ph.D. | 1 | 1 |
| Dinesh V. Patel, PhD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.